View highlights and coverage from leading international Endocrinology congresses
Conference Hub Content
This opinion piece introduces a novel concept termed as “wellness endocrinology”. Wellness endocrinology can be defined as the discipline which utilizes knowledge of endocrine physiology and pharmacology to ensure optimal biopsychosocial health for the population at large. The authors describe the rationale, scope, spectrum and utility of the framework, and call for a wellness-based or […]
Insulin at 100: a life-saving discovery but more remains to be done
2021 marks the centenary of the discovery of insulin. It is important to remind ourselves that this life-saving medication still remains beyond the reach of many people with diabetes who need it. Find out more at: https://worlddiabetesday.org/about/insulin-at-100/ Support: Published in collaboration with the International Diabetes Federation.
IDF Congress 2021, Bangkok, Thailand
The International Diabetes Federation (IDF) Congress 2021 will be held in Bangkok, Thailand and online on the IDF Congress virtual platform, on 6-9 December 2021. Find out more at: www.idf.org/congress Support: Published in collaboration with the International Diabetes Federation.
Juliana Chan, EASD 2020 – COVID-19 and type 1 diabetes
We spoke with Prof. Juliana Chan (The Chinese University of Hong Kong, Hong Kong) following her session on COVID-19 and the impact on patients with type 1 diabetes. Questions What key areas of diabetes and COVID-19 were discussed at EASD 2020? (0:05) How do you think the COVID-19 pandemic has affected treatment both now and […]
Tina Vilsbøll, EASD 2020 – Oral GLP-1RA therapy and individualized care
We were delighted to speak with Prof. Tina Vilsbøll (University of Copenhagen, Copenhagen, Denmark) about the approval of semaglutide and the impact on the GLP-1RA landscape, and the movement towards individualizing care in patients with type 2 diabetes. Questions What has been the impact of the approval of oral semaglutide in the GLP-1RA landscape? (0:15) […]
Gian Paolo Fadini, EASD 2020 – Highlights from EASD 2020
We were delighted to speak with Dr Gian Paolo Fadini (University of Padova, Venetian Institute of Molecular Medicine, Padova, Italy) about his highlights from the virtual EASD 2020 meeting. Disclosures: Dr Gian Paolo Fadini has received lecture fees or grant support from Abbott, AstraZeneca, Boehringer, Lilly, Merck-Sharp and Dohme, Mundipharma, Novartis Novo Nordisk, Sanofi […]
Gian Paolo Fadini, EASD 2020 – Highlights from the Minkowski Lecture
We were delighted to catch-up with Dr Gian Paolo Fadini (University of Padova, Venetian Institute of Molecular Medicine, Padova, Italy) to talk about his Minkowski Lecture on bone marrow, circulating stem cells and diabetes. Disclosures: Dr Gian Paolo Fadini has received lecture fees or grant support from Abbott, AstraZeneca, Boehringer, Lilly, Merck-Sharp and Dohme, […]
Mathias Ried-Larsen, EASD 2020 – Effects of cycling and mortality rates in patients with diabetes
We caught up with Dr Mathias Ried-Larsen (Centre for Physical Activity Research, Rigshospitalet) to discuss the results of his study into the effects of cycling on all-cause and cardiovascular mortality among people with diabetes. Questions Tell us about your study into the effects of cycle training on all-cause and cardiovascular mortality? (0:06) What challenges affect […]
Frank Snoek, EASD 2020 – Psychological aspects of diabetes
Prof. Frank Snoek (Amsterdam University Medical Centers, Amsterdam, The Netherlands) founder and member of the PSAD Study Group, discusses the key psychosocial issues patients face on a daily basis and during the COVID-19 pandemic. Disclosures: Prof. Frank Snoek has nothing to disclose. Support: Interview and filming supported by Touch Medical Media. Filmed as a highlight […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!